Takaomi Sanda

Sanda Takaomi

Appointment(s)
  • Assistant Professor, Department of Medicine
  • Principal Investigator, Cancer Science Institute of Singapore, National University of Singapore
Academic Qualifications
  • PhD, Nagoya City University Graduate School of Medical Sciences, Japan
  • MD, Nagoya City University Medical School, Japan
Research Interest(s)
  • T Cell Leukaemia
  • Hematopoiesi
  • Transcription Factors
  • Tyrosine Kinases
  • Zebrafish
  • Lymphoma
  • Others
Recent Publications
  • 1. Mansour MR, Abraham BJ, Anders L, Berezovskaya A, Gutierrez A, Durbin AD, Etchin J, Lawton L, Sallan SE, Silverman LB, Loh ML, Hunger SP, Sanda T, Young RA, Look AT. 2014 Dec. Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element. Science. 346(6215):1373-7. doi: 10.1126/science.1259037. 25394790.
  • 2. Barceló C, Etchin J, Mansour MR, Sanda T, Ginesta MM, Sanchez-Arévalo Lobo VJ, Real FX, Capellà G, Estanyol JM, Jaumot M, Look AT, Agell N. 2014 Oct. Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells. Gastroenterology. 147(4):882-892.e8. doi: 10.1053/j.gastro.2014.06.041. 24998203.
  • 3. Moore NF, Azarova AM, Bhatnagar N, Ross KN, Drake LE, Frumm S, Liu QS, Christie AL, Sanda T, Chesler L, Kung AL, Gray NS, Stegmaier K, George RE. 2014 Sep. Molecular rationale for the use of PI3K/AKT/mTOR pathway inhibitors in combination with crizotinib in ALK-mutated neuroblastoma. Oncotarget. 5(18):8737-49. doi: 10.18632/oncotarget.2372. 25228590.
  • 4. Mok MM, Du L, Wang CQ, Tergaonkar V, Liu TC, Yin Kham SK, Sanda T, Yeoh AE, Osato M. 2014 Jul. RUNX1 point mutations potentially identify a subset of early immature T-cell acute lymphoblastic leukaemia that may originate from differentiated T-cells. Gene. 545(1):111-6. doi: 10.1016/j.gene.2014.04.074. 24792891.
  • 5. Kwiatkowski N, Zhang T, Rahl PB, Abraham BJ, Reddy J, Ficarro SB, Dastur A, Amzallag A, Ramaswamy S, Tesar B, Jenkins CE, Hannett NM, McMillin D, Sanda T, Sim T, Kim ND, Look T, Mitsiades CS, Weng AP, Brown JR, Benes CH, Marto JA, Young RA, Gray NS. 2014 Jul. Targeting transcription regulation in cancer with a covalent CDK7 inhibitor. Nature. 511(7511):616-20. doi: 10.1038/nature13393. 25043025.